comparemela.com

Latest Breaking News On - Digestive disease week - Page 8 : comparemela.com

GLP-2 Analog Reduces Need for Parenteral Support in Patients With Rare GI Condition

Better outcomes in short bowel syndrome and intestinal failure with apraglutide vs placebo

France generalSan diegoUnited statesFrancisca jolyRandy dotingaIronwood pharmaceuticalsDigestive disease week

Blood-Based Test for CRC Screening Hits Sensitivity, Specificity Endpoints

Test could fill a gap in CRC screening

United statesFort pierceAasma shaukatEd susmanUniversity of texas md anderson cancer centerYork university grossman school of medicineNew york university grossman schoolDigestive disease weekCancer center

Vonoprazan reduces heartburn symptoms as early as day 1 in nonerosive reflux disease

Vonoprazan reduces heartburn symptoms as early as day 1 in nonerosive reflux disease
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesHeather bieleLoren laineBymonica stonehillYale school of medicineYale schoolDigestive disease week

Dr Ajay Goel Discusses New Methods of Testing for EOCRC, Recurrence

Ajay Goel, PhD, AGAF, explains the significance of 2 new studies that found that early-onset colorectal cancer (EOCRC) and recurrence in CRC could both be predicted using new blood and tissue tests.

United statesAjay goelDepartment of molecular diagnosticsMolecular diagnosticsExperimental therapeuticsAmerican journalDigestive diseaseDigestive disease week

Key studies on GLP-1 drugs, alpha-gal syndrome, and liver disease medications to be presented at DDW 2024

Studies examining the risks of GLP-1 weight-loss drugs, distinguishing alpha-gal syndrome from other GI disorders, and comparing medications to slow the progression of liver disease in patients with alcohol-use disorder will be presented this week at Digestive Disease Week (DDW) 2024.

Digestive disease weekMayo clinic

vimarsana © 2020. All Rights Reserved.